

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.32390167 |
| 2 | cardiac myofibril assembly (GO:0055003) | 8.48416021 |
| 3 | actin-myosin filament sliding (GO:0033275) | 8.43215683 |
| 4 | muscle filament sliding (GO:0030049) | 8.43215683 |
| 5 | myofibril assembly (GO:0030239) | 8.02836642 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.68626521 |
| 7 | regulation of skeletal muscle contraction (GO:0014819) | 7.00472804 |
| 8 | actin-mediated cell contraction (GO:0070252) | 6.95137033 |
| 9 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.91693120 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.91122988 |
| 11 | cardiac muscle contraction (GO:0060048) | 6.78326250 |
| 12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.58941546 |
| 13 | cardiac muscle cell development (GO:0055013) | 6.27022714 |
| 14 | tricarboxylic acid cycle (GO:0006099) | 6.20261698 |
| 15 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.03817675 |
| 16 | regulation of actin filament-based movement (GO:1903115) | 6.02840989 |
| 17 | regulation of relaxation of muscle (GO:1901077) | 6.00515554 |
| 18 | plasma membrane repair (GO:0001778) | 5.99927585 |
| 19 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.96497841 |
| 20 | actomyosin structure organization (GO:0031032) | 5.96450640 |
| 21 | cardiac cell development (GO:0055006) | 5.88313785 |
| 22 | striated muscle contraction (GO:0006941) | 5.84713936 |
| 23 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.64059156 |
| 24 | carnitine shuttle (GO:0006853) | 5.52180636 |
| 25 | skeletal muscle fiber development (GO:0048741) | 5.48926834 |
| 26 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.48247078 |
| 27 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.42323207 |
| 28 | adult heart development (GO:0007512) | 5.41470291 |
| 29 | cardiac muscle hypertrophy (GO:0003300) | 5.38647722 |
| 30 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.28149183 |
| 31 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.27248964 |
| 32 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.26009067 |
| 33 | actin filament-based movement (GO:0030048) | 5.24639659 |
| 34 | regulation of cell communication by electrical coupling (GO:0010649) | 5.23558714 |
| 35 | heart process (GO:0003015) | 5.21726263 |
| 36 | heart contraction (GO:0060047) | 5.21726263 |
| 37 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.21164878 |
| 38 | regulation of sarcomere organization (GO:0060297) | 5.21061988 |
| 39 | striated muscle hypertrophy (GO:0014897) | 5.16577847 |
| 40 | muscle tissue morphogenesis (GO:0060415) | 5.12188267 |
| 41 | heart trabecula formation (GO:0060347) | 5.03247229 |
| 42 | myotube cell development (GO:0014904) | 5.02528757 |
| 43 | regulation of striated muscle contraction (GO:0006942) | 4.99409073 |
| 44 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.98613044 |
| 45 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.91428143 |
| 46 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.88730486 |
| 47 | fatty acid transmembrane transport (GO:1902001) | 4.74080450 |
| 48 | skeletal muscle contraction (GO:0003009) | 4.70030232 |
| 49 | glucan biosynthetic process (GO:0009250) | 4.62866299 |
| 50 | glycogen biosynthetic process (GO:0005978) | 4.62866299 |
| 51 | muscle hypertrophy (GO:0014896) | 4.58196212 |
| 52 | muscle fiber development (GO:0048747) | 4.56863133 |
| 53 | regulation of coenzyme metabolic process (GO:0051196) | 4.49226875 |
| 54 | regulation of cofactor metabolic process (GO:0051193) | 4.49226875 |
| 55 | regulation of membrane repolarization (GO:0060306) | 4.48729660 |
| 56 | glucan catabolic process (GO:0009251) | 4.45446150 |
| 57 | regulation of the force of heart contraction (GO:0002026) | 4.44186406 |
| 58 | creatine metabolic process (GO:0006600) | 4.37557376 |
| 59 | skeletal muscle tissue development (GO:0007519) | 4.32837427 |
| 60 | cellular polysaccharide catabolic process (GO:0044247) | 4.18478784 |
| 61 | response to inactivity (GO:0014854) | 4.16917800 |
| 62 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.15816701 |
| 63 | positive regulation of myotube differentiation (GO:0010831) | 4.15738383 |
| 64 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.13920287 |
| 65 | skeletal muscle adaptation (GO:0043501) | 4.12590013 |
| 66 | skeletal muscle tissue regeneration (GO:0043403) | 4.05806714 |
| 67 | cell communication involved in cardiac conduction (GO:0086065) | 4.03997741 |
| 68 | carnitine transmembrane transport (GO:1902603) | 4.03957810 |
| 69 | muscle hypertrophy in response to stress (GO:0003299) | 4.01295084 |
| 70 | cardiac muscle adaptation (GO:0014887) | 4.01295084 |
| 71 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.01295084 |
| 72 | muscle cell cellular homeostasis (GO:0046716) | 4.00968032 |
| 73 | muscle contraction (GO:0006936) | 3.98753962 |
| 74 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.96339144 |
| 75 | oxidative phosphorylation (GO:0006119) | 3.94495233 |
| 76 | striated muscle adaptation (GO:0014888) | 3.88616359 |
| 77 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.86089347 |
| 78 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.83519249 |
| 79 | ATP synthesis coupled proton transport (GO:0015986) | 3.83519249 |
| 80 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.82298187 |
| 81 | striated muscle cell development (GO:0055002) | 3.82230282 |
| 82 | regulation of cardiac muscle contraction (GO:0055117) | 3.81715709 |
| 83 | muscle adaptation (GO:0043500) | 3.81016053 |
| 84 | 2-oxoglutarate metabolic process (GO:0006103) | 3.79861025 |
| 85 | negative regulation of potassium ion transport (GO:0043267) | 3.78184558 |
| 86 | fructose metabolic process (GO:0006000) | 3.77822830 |
| 87 | regulation of ATPase activity (GO:0043462) | 3.77593410 |
| 88 | regulation of ATP catabolic process (GO:1903289) | 3.77593410 |
| 89 | NADH metabolic process (GO:0006734) | 3.75946919 |
| 90 | polysaccharide catabolic process (GO:0000272) | 3.75664493 |
| 91 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.75441278 |
| 92 | gluconeogenesis (GO:0006094) | 3.75044079 |
| 93 | regulation of heart rate (GO:0002027) | 3.72333474 |
| 94 | muscle system process (GO:0003012) | 3.71705745 |
| 95 | cardiac muscle cell action potential (GO:0086001) | 3.71080915 |
| 96 | respiratory electron transport chain (GO:0022904) | 3.69758938 |
| 97 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.68892985 |
| 98 | amino-acid betaine transport (GO:0015838) | 3.66840834 |
| 99 | carnitine transport (GO:0015879) | 3.66840834 |
| 100 | glycogen metabolic process (GO:0005977) | 3.63351059 |
| 101 | negative regulation of protein localization to cell surface (GO:2000009) | 3.61347744 |
| 102 | regulation of sulfur metabolic process (GO:0042762) | 3.60390474 |
| 103 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.60123125 |
| 104 | electron transport chain (GO:0022900) | 3.58302967 |
| 105 | relaxation of cardiac muscle (GO:0055119) | 3.57974867 |
| 106 | glucan metabolic process (GO:0044042) | 3.57032766 |
| 107 | cellular glucan metabolic process (GO:0006073) | 3.57032766 |
| 108 | muscle organ development (GO:0007517) | 3.55104082 |
| 109 | regulation of cardioblast differentiation (GO:0051890) | 3.54551439 |
| 110 | muscle structure development (GO:0061061) | 3.53082901 |
| 111 | cell communication by electrical coupling (GO:0010644) | 3.49736500 |
| 112 | muscle cell fate commitment (GO:0042693) | 3.48626016 |
| 113 | positive regulation of cation channel activity (GO:2001259) | 3.47752412 |
| 114 | regulation of heart contraction (GO:0008016) | 3.46521515 |
| 115 | regulation of sequestering of triglyceride (GO:0010889) | 3.46426529 |
| 116 | glycogen catabolic process (GO:0005980) | 3.46205025 |
| 117 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.43913129 |
| 118 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.43913129 |
| 119 | regulation of muscle contraction (GO:0006937) | 3.43703571 |
| 120 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.40723388 |
| 121 | response to muscle activity (GO:0014850) | 3.39451563 |
| 122 | striated muscle atrophy (GO:0014891) | 3.38943837 |
| 123 | negative regulation of necroptotic process (GO:0060546) | 3.37952298 |
| 124 | regulation of myoblast differentiation (GO:0045661) | 3.37706111 |
| 125 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.37376554 |
| 126 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.37376554 |
| 127 | regulation of muscle system process (GO:0090257) | 3.33844757 |
| 128 | muscle atrophy (GO:0014889) | 3.33391900 |
| 129 | hexose biosynthetic process (GO:0019319) | 3.33321368 |
| 130 | response to activity (GO:0014823) | 3.31952930 |
| 131 | muscle cell development (GO:0055001) | 3.31199889 |
| 132 | muscle organ morphogenesis (GO:0048644) | 3.29672311 |
| 133 | oxaloacetate metabolic process (GO:0006107) | 3.28228099 |
| 134 | regulation of myotube differentiation (GO:0010830) | 3.22356325 |
| 135 | relaxation of muscle (GO:0090075) | 3.21770154 |
| 136 | cytidine metabolic process (GO:0046087) | 3.19967664 |
| 137 | cytidine catabolic process (GO:0006216) | 3.19967664 |
| 138 | cytidine deamination (GO:0009972) | 3.19967664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.56628816 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.64085490 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.43350711 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.33548813 |
| 5 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.09133700 |
| 6 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.09133700 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.97573810 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.31271678 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.29748638 |
| 10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.10761445 |
| 11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.04295005 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.01694042 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.73755196 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.63246189 |
| 15 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.45823144 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.16045377 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.12189389 |
| 18 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.04609442 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.00078900 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.97473256 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.87596185 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.87111555 |
| 23 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.84441381 |
| 24 | * MYC_22102868_ChIP-Seq_BL_Human | 1.78724827 |
| 25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.77025785 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74546998 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72455511 |
| 28 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.66693606 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65793951 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.60758490 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.59947971 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.55162770 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52387190 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.50085064 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46671694 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45013219 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.44296474 |
| 38 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.43495259 |
| 39 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.40441231 |
| 40 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.39731328 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38873720 |
| 42 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.36692391 |
| 43 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32799455 |
| 44 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.28214088 |
| 45 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28181514 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27904691 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27671815 |
| 48 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.25112463 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.24076602 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22080309 |
| 51 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20761521 |
| 52 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19136585 |
| 53 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.16379150 |
| 54 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.15530386 |
| 55 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15118099 |
| 56 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.12903686 |
| 57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10895731 |
| 58 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.10546166 |
| 59 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.10464404 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10250965 |
| 61 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.07874619 |
| 62 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07628508 |
| 63 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07082708 |
| 64 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.05068762 |
| 65 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04593884 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04566367 |
| 67 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.04360145 |
| 68 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.03665469 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.03365187 |
| 70 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.03298358 |
| 71 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03133678 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02795886 |
| 73 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02536816 |
| 74 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02316229 |
| 75 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02303387 |
| 76 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01574098 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00230189 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99904077 |
| 79 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99301702 |
| 80 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.98904681 |
| 81 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.98902641 |
| 82 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98373253 |
| 83 | * MAF_26560356_Chip-Seq_TH2_Human | 0.97849357 |
| 84 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97685659 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97571326 |
| 86 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.96431192 |
| 87 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.96077726 |
| 88 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.95466039 |
| 89 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94736724 |
| 90 | P68_20966046_ChIP-Seq_HELA_Human | 0.94228652 |
| 91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92529901 |
| 92 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.92262565 |
| 93 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.92048860 |
| 94 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.91042689 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90062820 |
| 96 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89445405 |
| 97 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89102018 |
| 98 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.88973856 |
| 99 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88618331 |
| 100 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.88438208 |
| 101 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.87199394 |
| 102 | * MAF_26560356_Chip-Seq_TH1_Human | 0.86037317 |
| 103 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85924164 |
| 104 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.85761040 |
| 105 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.85566953 |
| 106 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.85366716 |
| 107 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84634187 |
| 108 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.84593851 |
| 109 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.83818275 |
| 110 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.83184339 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82739140 |
| 112 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.82612655 |
| 113 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82306350 |
| 114 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.82081306 |
| 115 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.82009313 |
| 116 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.81763727 |
| 117 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81698257 |
| 118 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.81609345 |
| 119 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.81478962 |
| 120 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80825099 |
| 121 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.80776277 |
| 122 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.80694399 |
| 123 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.80004689 |
| 124 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79324614 |
| 125 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79130562 |
| 126 | CJUN_26792858_Chip-Seq_BT549_Human | 0.78851490 |
| 127 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.78367557 |
| 128 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.77751877 |
| 129 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.77671397 |
| 130 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.77602157 |
| 131 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.76379199 |
| 132 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.75898889 |
| 133 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.75448420 |
| 134 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.75290075 |
| 135 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.75257950 |
| 136 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.73254825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.34102460 |
| 2 | MP0003646_muscle_fatigue | 5.83343503 |
| 3 | MP0004084_abnormal_cardiac_muscle | 5.51323519 |
| 4 | MP0000751_myopathy | 5.23638991 |
| 5 | MP0004036_abnormal_muscle_relaxation | 4.58714315 |
| 6 | MP0000749_muscle_degeneration | 4.49369333 |
| 7 | MP0004215_abnormal_myocardial_fiber | 4.31393325 |
| 8 | MP0005330_cardiomyopathy | 3.79015353 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.37256828 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.29636301 |
| 11 | MP0002972_abnormal_cardiac_muscle | 3.04881906 |
| 12 | MP0002106_abnormal_muscle_physiology | 2.93909860 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.93562077 |
| 14 | MP0000750_abnormal_muscle_regeneration | 2.85832347 |
| 15 | MP0008775_abnormal_heart_ventricle | 2.74908577 |
| 16 | MP0004130_abnormal_muscle_cell | 2.67850210 |
| 17 | MP0003137_abnormal_impulse_conducting | 2.67320518 |
| 18 | MP0002269_muscular_atrophy | 2.62242813 |
| 19 | MP0010630_abnormal_cardiac_muscle | 2.57602119 |
| 20 | MP0005385_cardiovascular_system_phenoty | 2.48862226 |
| 21 | MP0001544_abnormal_cardiovascular_syste | 2.48862226 |
| 22 | MP0000747_muscle_weakness | 2.44259041 |
| 23 | MP0005369_muscle_phenotype | 2.36278467 |
| 24 | MP0000759_abnormal_skeletal_muscle | 2.32015784 |
| 25 | MP0004484_altered_response_of | 2.32014905 |
| 26 | MP0006138_congestive_heart_failure | 2.18617536 |
| 27 | MP0003828_pulmonary_edema | 2.14810220 |
| 28 | MP0004510_myositis | 2.09680684 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 2.01386767 |
| 30 | MP0004085_abnormal_heartbeat | 1.91989091 |
| 31 | MP0004233_abnormal_muscle_weight | 1.89321607 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.79336474 |
| 33 | MP0002332_abnormal_exercise_endurance | 1.61827474 |
| 34 | MP0002127_abnormal_cardiovascular_syste | 1.54302224 |
| 35 | MP0003950_abnormal_plasma_membrane | 1.44264496 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.41497188 |
| 37 | MP0003567_abnormal_fetal_cardiomyocyte | 1.24864092 |
| 38 | MP0000343_altered_response_to | 1.22018841 |
| 39 | MP0000266_abnormal_heart_morphology | 1.13286893 |
| 40 | MP0005670_abnormal_white_adipose | 1.13053430 |
| 41 | MP0004185_abnormal_adipocyte_glucose | 1.11132791 |
| 42 | MP0001661_extended_life_span | 1.04157031 |
| 43 | MP0006035_abnormal_mitochondrial_morpho | 1.01618684 |
| 44 | MP0002234_abnormal_pharynx_morphology | 1.00353757 |
| 45 | MP0004270_analgesia | 0.99105853 |
| 46 | MP0005375_adipose_tissue_phenotype | 0.96604199 |
| 47 | MP0002108_abnormal_muscle_morphology | 0.96519894 |
| 48 | MP0005165_increased_susceptibility_to | 0.96095953 |
| 49 | MP0003279_aneurysm | 0.95578356 |
| 50 | MP0000733_abnormal_muscle_development | 0.94401395 |
| 51 | MP0010368_abnormal_lymphatic_system | 0.87560234 |
| 52 | MP0005266_abnormal_metabolism | 0.84973828 |
| 53 | MP0000230_abnormal_systemic_arterial | 0.77255297 |
| 54 | MP0003806_abnormal_nucleotide_metabolis | 0.77114193 |
| 55 | MP0002128_abnormal_blood_circulation | 0.75886898 |
| 56 | MP0000372_irregular_coat_pigmentation | 0.75098640 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 0.72977002 |
| 58 | MP0003566_abnormal_cell_adhesion | 0.72659358 |
| 59 | MP0005451_abnormal_body_composition | 0.72225987 |
| 60 | MP0000685_abnormal_immune_system | 0.67719120 |
| 61 | MP0002971_abnormal_brown_adipose | 0.62676801 |
| 62 | MP0005623_abnormal_meninges_morphology | 0.59245757 |
| 63 | MP0000013_abnormal_adipose_tissue | 0.57503100 |
| 64 | MP0001879_abnormal_lymphatic_vessel | 0.55866469 |
| 65 | MP0000003_abnormal_adipose_tissue | 0.54513845 |
| 66 | MP0000767_abnormal_smooth_muscle | 0.54303815 |
| 67 | MP0004147_increased_porphyrin_level | 0.53823099 |
| 68 | MP0005645_abnormal_hypothalamus_physiol | 0.52970874 |
| 69 | MP0008961_abnormal_basal_metabolism | 0.52107210 |
| 70 | MP0001790_abnormal_immune_system | 0.50689342 |
| 71 | MP0005387_immune_system_phenotype | 0.50689342 |
| 72 | MP0008569_lethality_at_weaning | 0.50304584 |
| 73 | MP0003763_abnormal_thymus_physiology | 0.49268948 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 0.49234321 |
| 75 | MP0005166_decreased_susceptibility_to | 0.49153611 |
| 76 | MP0002909_abnormal_adrenal_gland | 0.48145931 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 0.46948299 |
| 78 | MP0004043_abnormal_pH_regulation | 0.46620175 |
| 79 | MP0002925_abnormal_cardiovascular_devel | 0.45841971 |
| 80 | MP0001800_abnormal_humoral_immune | 0.40585579 |
| 81 | MP0005671_abnormal_response_to | 0.38323707 |
| 82 | MP0001853_heart_inflammation | 0.36329107 |
| 83 | MP0003984_embryonic_growth_retardation | 0.35893462 |
| 84 | MP0002088_abnormal_embryonic_growth/wei | 0.35422601 |
| 85 | MP0004134_abnormal_chest_morphology | 0.35222313 |
| 86 | MP0008874_decreased_physiological_sensi | 0.35077894 |
| 87 | MP0001784_abnormal_fluid_regulation | 0.34971497 |
| 88 | MP0002166_altered_tumor_susceptibility | 0.34940931 |
| 89 | MP0003045_fibrosis | 0.34846626 |
| 90 | MP0004272_abnormal_basement_membrane | 0.34757408 |
| 91 | MP0001614_abnormal_blood_vessel | 0.34411735 |
| 92 | MP0003879_abnormal_hair_cell | 0.34028298 |
| 93 | MP0003948_abnormal_gas_homeostasis | 0.32638705 |
| 94 | MP0005334_abnormal_fat_pad | 0.32328503 |
| 95 | MP0009384_cardiac_valve_regurgitation | 0.31684856 |
| 96 | MP0005535_abnormal_body_temperature | 0.29389602 |
| 97 | MP0005275_abnormal_skin_tensile | 0.29253986 |
| 98 | MP0008438_abnormal_cutaneous_collagen | 0.28776671 |
| 99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.28322997 |
| 100 | MP0005187_abnormal_penis_morphology | 0.28090358 |
| 101 | MP0009672_abnormal_birth_weight | 0.27027955 |
| 102 | MP0001346_abnormal_lacrimal_gland | 0.26772969 |
| 103 | MP0000249_abnormal_blood_vessel | 0.26765719 |
| 104 | MP0005332_abnormal_amino_acid | 0.26422656 |
| 105 | MP0002138_abnormal_hepatobiliary_system | 0.25967397 |
| 106 | MP0001835_abnormal_antigen_presentation | 0.24594622 |
| 107 | MP0001727_abnormal_embryo_implantation | 0.24591405 |
| 108 | MP0009115_abnormal_fat_cell | 0.23298696 |
| 109 | MP0001299_abnormal_eye_distance/ | 0.22906627 |
| 110 | MP0003303_peritoneal_inflammation | 0.22778221 |
| 111 | MP0004142_abnormal_muscle_tone | 0.22628489 |
| 112 | MP0009840_abnormal_foam_cell | 0.20841090 |
| 113 | MP0002118_abnormal_lipid_homeostasis | 0.20674804 |
| 114 | MP0005000_abnormal_immune_tolerance | 0.20358197 |
| 115 | MP0005595_abnormal_vascular_smooth | 0.20339472 |
| 116 | MP0005452_abnormal_adipose_tissue | 0.19571770 |
| 117 | MP0002822_catalepsy | 0.18675521 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.17883558 |
| 119 | MP0002723_abnormal_immune_serum | 0.17302507 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.16882095 |
| 121 | MP0003959_abnormal_lean_body | 0.16775121 |
| 122 | MP0002114_abnormal_axial_skeleton | 0.16530528 |
| 123 | MP0009780_abnormal_chondrocyte_physiolo | 0.16399707 |
| 124 | MP0002638_abnormal_pupillary_reflex | 0.16394700 |
| 125 | MP0005083_abnormal_biliary_tract | 0.16266318 |
| 126 | MP0002877_abnormal_melanocyte_morpholog | 0.15962170 |
| 127 | MP0002452_abnormal_antigen_presenting | 0.15025647 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.14989465 |
| 129 | MP0002933_joint_inflammation | 0.14666340 |
| 130 | MP0005380_embryogenesis_phenotype | 0.13880922 |
| 131 | MP0001672_abnormal_embryogenesis/_devel | 0.13880922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.55089770 |
| 2 | Exercise-induced myalgia (HP:0003738) | 7.11040416 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 7.08092317 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 6.85926518 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.61783135 |
| 6 | Ventricular tachycardia (HP:0004756) | 6.31969423 |
| 7 | Muscle fiber splitting (HP:0003555) | 5.82955638 |
| 8 | Subaortic stenosis (HP:0001682) | 5.54519718 |
| 9 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.54519718 |
| 10 | Myoglobinuria (HP:0002913) | 5.46311231 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 5.39843266 |
| 12 | Atrial fibrillation (HP:0005110) | 5.37362288 |
| 13 | Hyporeflexia of lower limbs (HP:0002600) | 5.29259584 |
| 14 | Primary atrial arrhythmia (HP:0001692) | 5.02793873 |
| 15 | Lipoatrophy (HP:0100578) | 4.94443529 |
| 16 | Supraventricular tachycardia (HP:0004755) | 4.86081219 |
| 17 | Supraventricular arrhythmia (HP:0005115) | 4.75932858 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 4.61721173 |
| 19 | Rhabdomyolysis (HP:0003201) | 4.33471054 |
| 20 | Right ventricular cardiomyopathy (HP:0011663) | 4.31907444 |
| 21 | Asymmetric septal hypertrophy (HP:0001670) | 4.24540875 |
| 22 | Syncope (HP:0001279) | 4.23618005 |
| 23 | Difficulty running (HP:0009046) | 4.16956236 |
| 24 | Increased connective tissue (HP:0009025) | 4.15447988 |
| 25 | Dilated cardiomyopathy (HP:0001644) | 4.12841431 |
| 26 | Bundle branch block (HP:0011710) | 4.09538191 |
| 27 | Muscle fiber inclusion bodies (HP:0100299) | 4.07145459 |
| 28 | Palpitations (HP:0001962) | 4.04566499 |
| 29 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.02143122 |
| 30 | Prolonged QT interval (HP:0001657) | 3.95515805 |
| 31 | Myotonia (HP:0002486) | 3.77845484 |
| 32 | Type 1 muscle fiber predominance (HP:0003803) | 3.74038997 |
| 33 | Ventricular arrhythmia (HP:0004308) | 3.73533158 |
| 34 | Calcaneovalgus deformity (HP:0001848) | 3.58443926 |
| 35 | Heart block (HP:0012722) | 3.45610954 |
| 36 | Ventricular fibrillation (HP:0001663) | 3.34754499 |
| 37 | Nemaline bodies (HP:0003798) | 3.32510779 |
| 38 | Atrioventricular block (HP:0001678) | 3.29084125 |
| 39 | Muscle stiffness (HP:0003552) | 3.26577017 |
| 40 | Absent phalangeal crease (HP:0006109) | 3.26206470 |
| 41 | Abnormal atrioventricular conduction (HP:0005150) | 3.24985593 |
| 42 | Difficulty climbing stairs (HP:0003551) | 3.16470939 |
| 43 | Deformed tarsal bones (HP:0008119) | 3.15383414 |
| 44 | Malignant hyperthermia (HP:0002047) | 2.93026779 |
| 45 | Abnormal EKG (HP:0003115) | 2.86371938 |
| 46 | Distal lower limb muscle weakness (HP:0009053) | 2.79262058 |
| 47 | Left ventricular hypertrophy (HP:0001712) | 2.77765360 |
| 48 | Areflexia of lower limbs (HP:0002522) | 2.77275770 |
| 49 | Neck muscle weakness (HP:0000467) | 2.77243418 |
| 50 | Increased variability in muscle fiber diameter (HP:0003557) | 2.71104414 |
| 51 | Abnormal finger flexion creases (HP:0006143) | 2.68829683 |
| 52 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.65955418 |
| 53 | Bulbar palsy (HP:0001283) | 2.65163431 |
| 54 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.62011435 |
| 55 | Hepatic necrosis (HP:0002605) | 2.55989437 |
| 56 | Acute necrotizing encephalopathy (HP:0006965) | 2.54030852 |
| 57 | Rimmed vacuoles (HP:0003805) | 2.45648995 |
| 58 | Limb-girdle muscle atrophy (HP:0003797) | 2.44371193 |
| 59 | Slender build (HP:0001533) | 2.43433318 |
| 60 | Ketoacidosis (HP:0001993) | 2.42836443 |
| 61 | Progressive muscle weakness (HP:0003323) | 2.40870480 |
| 62 | Distal arthrogryposis (HP:0005684) | 2.40784757 |
| 63 | Palmoplantar keratoderma (HP:0000982) | 2.39153779 |
| 64 | Round ear (HP:0100830) | 2.34922863 |
| 65 | Myopathic facies (HP:0002058) | 2.34269665 |
| 66 | Weak cry (HP:0001612) | 2.33490537 |
| 67 | Ragged-red muscle fibers (HP:0003200) | 2.27681475 |
| 68 | Fetal akinesia sequence (HP:0001989) | 2.26416384 |
| 69 | EMG: neuropathic changes (HP:0003445) | 2.26376875 |
| 70 | Hyperkalemia (HP:0002153) | 2.25810688 |
| 71 | Hepatocellular necrosis (HP:0001404) | 2.21551640 |
| 72 | Conjunctival hamartoma (HP:0100780) | 2.19401995 |
| 73 | Hypoglycemic coma (HP:0001325) | 2.18180628 |
| 74 | Abnormality of the neuromuscular junction (HP:0003398) | 2.17639943 |
| 75 | Fatigable weakness (HP:0003473) | 2.17639943 |
| 76 | Increased muscle lipid content (HP:0009058) | 2.17312771 |
| 77 | Acute encephalopathy (HP:0006846) | 2.17248215 |
| 78 | Exercise intolerance (HP:0003546) | 2.13752216 |
| 79 | Hypoplastic ischia (HP:0003175) | 2.12453116 |
| 80 | Generalized muscle weakness (HP:0003324) | 2.12442997 |
| 81 | Testicular atrophy (HP:0000029) | 2.12071280 |
| 82 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.11739788 |
| 83 | Progressive macrocephaly (HP:0004481) | 2.09343895 |
| 84 | Muscular dystrophy (HP:0003560) | 2.08632008 |
| 85 | Abnormality of the calcaneus (HP:0008364) | 2.06613946 |
| 86 | Spinal rigidity (HP:0003306) | 2.06096949 |
| 87 | Mitochondrial inheritance (HP:0001427) | 2.05960087 |
| 88 | Facial diplegia (HP:0001349) | 2.05629863 |
| 89 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.04390672 |
| 90 | Waddling gait (HP:0002515) | 2.03739971 |
| 91 | Hip contracture (HP:0003273) | 2.03665559 |
| 92 | Lower limb amyotrophy (HP:0007210) | 2.02975993 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.02114817 |
| 94 | Dicarboxylic aciduria (HP:0003215) | 2.02114817 |
| 95 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.99864924 |
| 96 | Cerebral edema (HP:0002181) | 1.99667616 |
| 97 | Distal lower limb amyotrophy (HP:0008944) | 1.99060247 |
| 98 | Abnormality of the foot musculature (HP:0001436) | 1.97903813 |
| 99 | Gowers sign (HP:0003391) | 1.97576557 |
| 100 | Sudden cardiac death (HP:0001645) | 1.96891480 |
| 101 | Increased CSF lactate (HP:0002490) | 1.96702285 |
| 102 | Scapular winging (HP:0003691) | 1.92702900 |
| 103 | Congestive heart failure (HP:0001635) | 1.91904926 |
| 104 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.91275950 |
| 105 | Ulnar deviation of the wrist (HP:0003049) | 1.89641541 |
| 106 | Increased intramyocellular lipid droplets (HP:0012240) | 1.89352095 |
| 107 | Pheochromocytoma (HP:0002666) | 1.86711014 |
| 108 | Foot dorsiflexor weakness (HP:0009027) | 1.84428291 |
| 109 | Abnormality of the ischium (HP:0003174) | 1.84047013 |
| 110 | Frequent falls (HP:0002359) | 1.83727023 |
| 111 | Large for gestational age (HP:0001520) | 1.83688468 |
| 112 | Lactic acidosis (HP:0003128) | 1.82901996 |
| 113 | Ketosis (HP:0001946) | 1.80012664 |
| 114 | Proximal amyotrophy (HP:0007126) | 1.79537708 |
| 115 | Abnormality of alanine metabolism (HP:0010916) | 1.78800011 |
| 116 | Hyperalaninemia (HP:0003348) | 1.78800011 |
| 117 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.78800011 |
| 118 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.77545431 |
| 119 | Double outlet right ventricle (HP:0001719) | 1.76319324 |
| 120 | Congenital malformation of the right heart (HP:0011723) | 1.76319324 |
| 121 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.68658822 |
| 122 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.68658822 |
| 123 | Pelvic girdle muscle weakness (HP:0003749) | 1.66631934 |
| 124 | Shoulder girdle muscle weakness (HP:0003547) | 1.62682336 |
| 125 | Paralysis (HP:0003470) | 1.58198734 |
| 126 | Limb-girdle muscle weakness (HP:0003325) | 1.56568337 |
| 127 | Nonprogressive disorder (HP:0003680) | 1.50760102 |
| 128 | Steppage gait (HP:0003376) | 1.49855504 |
| 129 | Long clavicles (HP:0000890) | 1.45934333 |
| 130 | Metatarsus adductus (HP:0001840) | 1.45367745 |
| 131 | Type 2 muscle fiber atrophy (HP:0003554) | 1.44859976 |
| 132 | Oligomenorrhea (HP:0000876) | 1.38510999 |
| 133 | Popliteal pterygium (HP:0009756) | 1.38229643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.26178110 |
| 2 | OBSCN | 5.34618906 |
| 3 | PHKG2 | 4.53591799 |
| 4 | PHKG1 | 4.53591799 |
| 5 | MYLK | 3.54428284 |
| 6 | DMPK | 3.13927082 |
| 7 | LMTK2 | 3.07917139 |
| 8 | PKN2 | 3.03646488 |
| 9 | PDK4 | 3.03620787 |
| 10 | PDK3 | 3.03620787 |
| 11 | TRIB3 | 2.77645697 |
| 12 | PIK3CA | 2.34347775 |
| 13 | STK24 | 2.26999003 |
| 14 | BCKDK | 2.25104854 |
| 15 | NEK1 | 2.20953115 |
| 16 | MUSK | 1.97596722 |
| 17 | PINK1 | 1.85764486 |
| 18 | PDK2 | 1.81312116 |
| 19 | TIE1 | 1.64845539 |
| 20 | MAP3K7 | 1.41648796 |
| 21 | MAP2K3 | 1.41073101 |
| 22 | PRPF4B | 1.35982111 |
| 23 | GRK7 | 1.25941273 |
| 24 | ILK | 1.22534897 |
| 25 | MAPK12 | 1.22194607 |
| 26 | NME1 | 1.21615559 |
| 27 | MAP3K13 | 1.16860102 |
| 28 | PRKD1 | 1.13366482 |
| 29 | PAK3 | 1.04008002 |
| 30 | CAMK2D | 1.02697338 |
| 31 | TRPM7 | 0.97793943 |
| 32 | CDC42BPA | 0.95520784 |
| 33 | PRKAA2 | 0.92108972 |
| 34 | MAPKAPK3 | 0.91632929 |
| 35 | PRKAA1 | 0.90459912 |
| 36 | ZAK | 0.88463816 |
| 37 | ROCK1 | 0.87035644 |
| 38 | FLT3 | 0.85788862 |
| 39 | CCNB1 | 0.82630375 |
| 40 | STK4 | 0.80758682 |
| 41 | MAP3K5 | 0.80006814 |
| 42 | PIK3CG | 0.79338687 |
| 43 | RIPK1 | 0.78887173 |
| 44 | TGFBR2 | 0.78869479 |
| 45 | LIMK1 | 0.74420464 |
| 46 | PKN1 | 0.74341512 |
| 47 | MOS | 0.72448768 |
| 48 | EPHB1 | 0.71374037 |
| 49 | STK38L | 0.70034286 |
| 50 | MARK1 | 0.68050119 |
| 51 | MAP3K3 | 0.66440855 |
| 52 | MAPK4 | 0.65765785 |
| 53 | NEK9 | 0.62897025 |
| 54 | DAPK3 | 0.62090282 |
| 55 | WNK4 | 0.61617993 |
| 56 | CAMK4 | 0.60087153 |
| 57 | INSRR | 0.58885253 |
| 58 | DYRK1B | 0.58883726 |
| 59 | KSR2 | 0.56329448 |
| 60 | KDR | 0.54504772 |
| 61 | JAK1 | 0.50357691 |
| 62 | PDGFRA | 0.47879905 |
| 63 | ROCK2 | 0.47594079 |
| 64 | RPS6KC1 | 0.46517401 |
| 65 | RPS6KL1 | 0.46517401 |
| 66 | SYK | 0.46466934 |
| 67 | PTK2B | 0.45246560 |
| 68 | PRKACB | 0.44865615 |
| 69 | PTK6 | 0.44075323 |
| 70 | WNK1 | 0.43892686 |
| 71 | MAP3K10 | 0.42759699 |
| 72 | CAMK2A | 0.41049531 |
| 73 | SIK1 | 0.40415856 |
| 74 | RPS6KA6 | 0.40121630 |
| 75 | CAMK1 | 0.39899138 |
| 76 | RIPK4 | 0.39053489 |
| 77 | CAMK2G | 0.38688262 |
| 78 | MAP2K1 | 0.38380545 |
| 79 | STK38 | 0.36624189 |
| 80 | EPHA3 | 0.35507377 |
| 81 | PDK1 | 0.35360677 |
| 82 | MAP3K14 | 0.35224901 |
| 83 | PDPK1 | 0.35119810 |
| 84 | TAOK2 | 0.35073302 |
| 85 | ARAF | 0.34817540 |
| 86 | MAP2K6 | 0.34775599 |
| 87 | PRKACA | 0.32701735 |
| 88 | AKT2 | 0.32458073 |
| 89 | BLK | 0.32361808 |
| 90 | PRKACG | 0.31761353 |
| 91 | ICK | 0.31528571 |
| 92 | MAP2K4 | 0.31139645 |
| 93 | MAP3K1 | 0.30262501 |
| 94 | RPS6KB2 | 0.29649031 |
| 95 | MAPK11 | 0.29392231 |
| 96 | PRKCH | 0.28431534 |
| 97 | CAMK2B | 0.28399919 |
| 98 | ERN1 | 0.27175341 |
| 99 | RPS6KA1 | 0.26491275 |
| 100 | SGK2 | 0.26453841 |
| 101 | FGFR4 | 0.26337221 |
| 102 | CDK19 | 0.26263917 |
| 103 | TYK2 | 0.25363632 |
| 104 | MARK3 | 0.24893445 |
| 105 | LRRK2 | 0.24347735 |
| 106 | MAP4K1 | 0.21841327 |
| 107 | EIF2AK3 | 0.21039411 |
| 108 | ERBB3 | 0.20744798 |
| 109 | PRKCE | 0.20591374 |
| 110 | SGK3 | 0.19732554 |
| 111 | JAK2 | 0.19404088 |
| 112 | EEF2K | 0.19148988 |
| 113 | PRKG1 | 0.18506717 |
| 114 | MARK2 | 0.18276595 |
| 115 | TBK1 | 0.18195399 |
| 116 | MAP3K9 | 0.17932588 |
| 117 | MTOR | 0.17818708 |
| 118 | RET | 0.17330882 |
| 119 | MAPK10 | 0.16215905 |
| 120 | MAPK7 | 0.16022195 |
| 121 | SGK1 | 0.15764381 |
| 122 | PRKCQ | 0.15581149 |
| 123 | MAP3K11 | 0.15437686 |
| 124 | ZAP70 | 0.15398578 |
| 125 | TAOK1 | 0.15190242 |
| 126 | FGFR3 | 0.14758257 |
| 127 | RPS6KB1 | 0.14471838 |
| 128 | RPS6KA3 | 0.14101455 |
| 129 | STK39 | 0.14029576 |
| 130 | MAPKAPK2 | 0.13179865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.82333633 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.40501349 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.23825441 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.95202269 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.89305575 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.19040316 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.05040389 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 3.02696654 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.83187356 |
| 10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.67451188 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.63685031 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.48149455 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.25785963 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.15436142 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.05591525 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97382619 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.88062904 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.83161416 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.78429477 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69024292 |
| 21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.43790008 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.34871412 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.31560644 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.31299578 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30316523 |
| 26 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.24354311 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21971350 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.19628160 |
| 29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.17149959 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12636805 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.12363884 |
| 32 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.11142096 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.07768817 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04653605 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01062850 |
| 36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95242946 |
| 37 | Asthma_Homo sapiens_hsa05310 | 0.93941319 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92872305 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92767824 |
| 40 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.90097865 |
| 41 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.86796766 |
| 42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86502778 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.85483525 |
| 44 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84553669 |
| 45 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82886544 |
| 46 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81577757 |
| 47 | Focal adhesion_Homo sapiens_hsa04510 | 0.81237447 |
| 48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.81071950 |
| 49 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71974708 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 0.70240192 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69410910 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68503301 |
| 53 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.66241141 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65854822 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65642957 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65063188 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64915960 |
| 58 | Long-term potentiation_Homo sapiens_hsa04720 | 0.64073823 |
| 59 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63429083 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62851696 |
| 61 | Tight junction_Homo sapiens_hsa04530 | 0.58037815 |
| 62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56793527 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55074501 |
| 64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48995098 |
| 65 | Leishmaniasis_Homo sapiens_hsa05140 | 0.47515478 |
| 66 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46674314 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43116538 |
| 68 | Renin secretion_Homo sapiens_hsa04924 | 0.42160104 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41816648 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.39618828 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.37934052 |
| 72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.37442731 |
| 73 | Adherens junction_Homo sapiens_hsa04520 | 0.37128534 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36646038 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.36076955 |
| 76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.34451343 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.34396665 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.33590071 |
| 79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.32354177 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.31091629 |
| 81 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.31086909 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30938579 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29624106 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28262735 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28156287 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26917914 |
| 87 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.26337623 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.26252952 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25633219 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25529325 |
| 91 | Insulin secretion_Homo sapiens_hsa04911 | 0.23719482 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.22821628 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22742743 |
| 94 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.22654774 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.21296642 |
| 96 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.20277079 |
| 97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.19914839 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.18681284 |
| 99 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.18555690 |
| 100 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.18267606 |
| 101 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.18008330 |
| 102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.17551325 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17398891 |
| 104 | Salivary secretion_Homo sapiens_hsa04970 | 0.16966030 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16846616 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16512111 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.16147442 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15688582 |
| 109 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.14573213 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.14405902 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.14318385 |
| 112 | HTLV-I infection_Homo sapiens_hsa05166 | 0.14140131 |
| 113 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.13514607 |
| 114 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.12395907 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.12193304 |
| 116 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.11585209 |
| 117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.09968330 |
| 118 | Circadian entrainment_Homo sapiens_hsa04713 | 0.09878190 |
| 119 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.07461225 |
| 120 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.06887231 |
| 121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.05386388 |
| 122 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.03197489 |
| 123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.02732856 |
| 124 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.01900617 |
| 125 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.01674844 |
| 126 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.00661586 |
| 127 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | -0.0260963 |
| 128 | Gap junction_Homo sapiens_hsa04540 | -0.0250870 |
| 129 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | -0.0170345 |
| 130 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0147158 |

